Page last updated on July 18, 2024
ALTEROLA BIOTECH INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-07-17 18:04:07 EDT.
Filings
10-K filed on 2024-07-17
ALTEROLA BIOTECH INC. filed a 10-K at 2024-07-17 18:04:07 EDT
Accession Number: 0001663577-24-000211
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity We rely on our information technology to operate our business. As such, we have policies and processes designed to protect our information technology systems, some of which are managed by third parties, and resolve issues in a timely manner in the event of a cybersecurity threat or incident. We have designed our business applications and hosting services to minimize the impact that cybersecurity incidents could have on our business and have identified back-up systems where appropriate. We seek to further mitigate cybersecurity risks through a combination of monitoring and detection activities, use of anti-malware applications, employee training, quality audits and communication and reporting structures, among other processes. We engage a third-party consultant to assist us with our cybersecurity risk management framework, including the monitoring and detection of cybersecurity threats and responding to any cybersecurity threats or incidents. Our third-party consultant team is managed by our Chief Financial Officer who reports to the audit committee or board, as appropriate. As of March 31, 2024, we have not identified any indication of a cybersecurity incident that would have a material impact on our business and consolidated financial statements.
Company Information
Name | ALTEROLA BIOTECH INC. |
CIK | 0001442999 |
SIC Description | Medicinal Chemicals & Botanical Products |
Ticker | ABTI - OTC |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | March 30 |